Education: WO
Working hours: 28 hours a week
Salary: € 3.217 - € 4.077
Closing date: October 13
Make more donor livers transplantable through cutting-edge transplantation research.
Improving the quality and availability of donor organs is one of the greatest challenges in modern transplantation. At the University of Groningen and UMCG, you will contribute to the development of next-generation technologies aimed at assessing, protecting, and repairing donor livers before transplantation. This PhD project is embedded within the multidisciplinary CRISPR-CRYSTAL consortium, bringing together experts in transplantation, nanotechnology, quantum sensing, mitochondrial medicine, and epigenetic editing. The project combines fundamental science with a clear path toward clinical translation, offering the opportunity to make a direct impact on patient care.
About your role
During machine perfusion, donor livers can be maintained outside the body, creating a unique opportunity to assess organ quality and deliver targeted therapies before transplantation. In this PhD project, you will develop and evaluate innovative strategies to detect, prevent, and repair oxidative stress-associated injury in high-risk donor livers.
Using a combination of cell models and human donor livers, you will investigate how these technologies can improve organ quality and increase the number of transplantable donor livers.
Your main responsibilities
The project will be conducted within the Department of Surgery at the University Medical Center Groningen, one of Europe's leading centers for machine perfusion and transplantation research. The UMCG performs pioneering research on donor organ preservation, viability assessment, and organ repair. This position is part of the University of Groningen PhD program. You will work in a highly interdisciplinary environment and collaborate closely with consortium partners QT Sense and Sulfateq. QT Sense develops quantum sensing technologies based on fluorescent nanodiamonds, while Sulfateq develops mitochondrial-targeted therapeutics. Together, these partners provide a unique ecosystem that combines academic excellence with industrial innovation. The project offers access to state-of-the-art perfusion facilities, advanced molecular biology laboratories, platforms, and unique human donor organ models. You will become part of an international team of clinicians, molecular biologists, pharmaceutical and translational scientists working to redefine the future of transplantation.
We are looking for an enthusiastic and highly motivated candidate with a strong interest in organ transplantation and ex situ machine perfusion, regenerative medicine, and translational biomedical research. You enjoy experimental work, can work independently, and are eager to collaborate across disciplines.
You have:
Experience with organ perfusion, nanoparticle delivery, CRISPR technologies, is considered an advantage but is not required.
Any questions? Do contact us.